|Congratulations to Dr Akram Zamani (left) and Dr Evelyn Tsantikos (right), who are recipients of the AMREP 2018 Collaborative Seed grant award for their research project, "A new player in microglial activation driving inflammation and pathology in traumatic brain injury [TBI]."|
TBI is a complex and poorly-understood pathology with long-term consequences, affecting the lives of children and young people well into adulthood. Identifying disease pathways that can provide scope for improved treatments is of utmost necessity and importance. This study will focus on how microglia - cells which provide the first and main form of active immune defence - act in the normal brain, and the researchers will then examine howthese cells respond to a brain injury.
Dr Zamani is a Postdoctoral Research fellow in Dr Bridgette Semple's Pediatric Neurotrauma Group, Department of Neuroscience; and Dr Tsantikos is a Research Officer in Associate Professor Margaret Hibb's Leukocyte Signalling Laboratory, which studies signalling pathways that play a role in immune system development, function and disease. Find out more about the AMREP collaborative seed grants: www.monash.edu/medicine/ccs/research/emcr/seed-grants
30 Nov 2018
|Dr Keith Potent presenting at the|
recent CCS GR symposium. He is
giving his PhD confirmation talk at
10.30 am on Monday 3 Dec 2018
CCS staff and students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the CCS intranet's Announcements page.
See CCS seminar index: www.monash.edu/medicine/ccs/headlines/events-calendar
|Mr James Lee was published this |
week in the World Journal of Surgery
- Australian Centre for Blood Diseases (ACBD)
- Allergy, Immunology and Respiratory Medicine (AIRMed)
- Immunology and Pathology
|Professor Ben Marsland|
The study, led by Professor Ben Marsland, a veski Innovation Fellow in the Department of Immunology and Pathology at Central Clinical School, Monash University, is published today in the journal Cell Host and Microbe.
|Dr James McMahon|
The recipients include Dr James McMahon, Head of The Alfred’s Department of Infectious Diseases Clinical Research Unit, who received a grant to expand a clinical trial to find rare infected cells in people on HIV treatment using a radioactive label followed by an MRI.
29 Nov 2018
|"What you see is what you've got". In MPI (far left), SPIO tracers|
are bright, not dark, and can be accurately quantified.
Main advantages of MPI over other imaging modalities:
(A) no background signal similar to PET but without the use of radiation,
(B) no tissue signal attenuation as seen with fluorescence imaging, and
(C) no image artefacts as seen in MRI. Image derived from Zheng et al
Professor Terry O'Brien, Head of the Department of Neuroscience and Associate Professor Christoph Hagemeyer, head of the NanoBiotechnology Laboratory at the Australian Centre for Blood Diseases at the Central Clinical School are Chief Investigators on an $898,450 LEIF grant to establish the first Magnetic Particle Imaging (MPI) facility in Australia. The lead investigator is Professor Gary Egan, Director of Monash Biomedical Imaging.
28 Nov 2018
|Dr Steven Petratos at a Red Lab Coat |
Day, raising awareness of MS research
27 Nov 2018
|Professor Merlin Thomas|
The award will support research into a new inhibitor which could help prevent and treat diabetes-related complications including heart attack, stroke or limb amputation.
Alex was supervised by Professors Karlheinz Peter (Baker Institute) and Alex Bobik (Baker and School of Clinical Sciences, Monash).
26 Nov 2018
|Channel News Asia interview with Prof|
- How serious is the diabetes situation worldwide?
- What are the implications of that on the way we're managing diabetes?
- We understand that by 2030, insulin will be beyond the reach of 41 million of the adults with type 2 diabetes who will need it worldwide. How critical is that problem, and how can we address that?
- Back to the roots of diabetes - we understand that genes might play a role in causing diabetes but lifestyle choices are important as well. What are your thoughts - which factor matters more? And what can we do to lower our risk of getting diabetes?